Condition
Systemic Lupus Erthematosus clinical trials and research
As of November 12, 2026, Find a Trial lists 9 Systemic Lupus Erthematosus clinical trials that are recruiting, at sites in 6 countries (most in China (4), United States (1), Hungary (1)). By phase: Phase 1/2 (3), Phase 1 (2), Early Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 6Countries
Newest Systemic Lupus Erthematosus clinical trials
All recruiting trials (9)
-
Gyrotonic exercise for adolescents with lupus who survived intensive care
This study tests whether a Gyrotonic exercise program can help teenagers with childhood-onset lupus who recently survived an intensive care stay and may have lingering post-ICU symptoms.
-
Budoprutug in systemic lupus erythematosus (SLE)
A phase 1b/2a study in adults with active SLE will test two-dose levels of Budoprutug given by two IV infusions 14 days apart to see if it lowers B cells and improves disease activity in people who haven’t fully responded to standard therapy.
-
GR1803 for systemic lupus erythematosus (SLE)
This trial will test GR1803 injections in people with active systemic lupus (SLE) to see if the drug is safe and helps control lupus symptoms.
-
BCD-256 alone or with divozilimab for lupus skin lesions
This will test whether BCD-256 by itself or together with divozilimab helps adults with mild-to-moderate systemic lupus who have active skin lesions.
-
Cardiovascular health in children and young adults with chronic conditions
This project will see if children and young adults (ages 6-25) with chronic health conditions show early signs of aging in large and small blood vessels using noninvasive imaging and clinical tests.
-
Universal CD19-targeting CAR-γδT cell therapy for refractory autoimmune diseases
This trial will try infusing universal CD19-targeting CAR-γδT cells into adults with refractory B cell–driven autoimmune diseases to see if removing autoreactive B cells improves symptoms.
-
Using CAR-NK cells to treat autoimmune diseases like lupus and nephrotic syndrome
This study is testing a new treatment using CAR-NK cells to see if it can help people with autoimmune diseases like lupus and nephrotic syndrome feel better.
-
Cell therapy using UC-MSCs for patients with lupus
This study is testing if a new treatment using stem cells from umbilical cords can help adults with lupus feel better and improve their kidney health.
-
Evaluating COVID-19 and influenza vaccine schedules for immunocompromised individuals
This study is testing different ways to give COVID-19 and flu vaccines to people with weakened immune systems to see which method works best for their protection.
Related topics
Quick answers
How many Systemic Lupus Erthematosus clinical trials are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in China (4 trials), United States (1 trial), Hungary (1 trial), Egypt (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 3, Phase 1: 2, Early Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.